Safety Profile of Mirvetuximab Soravtansine, a Folate...

Gynecologic Oncology 2020 / 03 Vol. 156; Iss. 3

Safety Profile of Mirvetuximab Soravtansine, a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Patients with Recurrent Ovarian Cancer

Essel, Kathleen G., Martin, Lainie P., O’Malley, David M., Matulonis, Ursula, Konner, Jason A., Birrer, Michael J., Moore, K.N.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
156
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2019.11.066
Date:
March, 2020
File:
PDF, 139 KB
2020
Conversion to is in progress
Conversion to is failed